KALARIS THERAPEUTICS INC (KLRS) Stock Analyst Ratings
NASDAQ:KLRS • US4829291065
10.98 USD
+0.74 (+7.23%)
At close: Feb 19, 2026
11.0087 USD
+0.03 (+0.26%)
After Hours: 2/19/2026, 8:12:02 PM
ChartMill assigns a Buy % Consensus number of 85% to KLRS. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 18.97. This target is 72.79% above the current price.
- KLRS was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about KLRS.
- In the previous month the buy percentage consensus was at a similar level.
- KLRS was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-23 | Chardan Capital | Initiate | Buy |
| 2025-11-03 | Citizens | Initiate | Market Outperform |
| 2025-09-03 | Raymond James | Initiate | Strong Buy |
| 2025-04-08 | William Blair | Initiate | Outperform |
KALARIS THERAPEUTICS INC / KLRS FAQ
What is the average price target for KALARIS THERAPEUTICS INC (KLRS) stock?
12 analysts have analysed KLRS and the average price target is 18.97 USD. This implies a price increase of 72.79% is expected in the next year compared to the current price of 10.98.
What is the consensus rating for KALARIS THERAPEUTICS INC (KLRS) stock?
The consensus rating for KALARIS THERAPEUTICS INC (KLRS) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.